USPTO trademark

GVOKE

RegisteredUSPTOWord and designClass 5

"GVOKE" is a word and design mark owned by Xeris Pharmaceuticals, Inc., filed at the USPTO on April 19, 2024. It is registered and covers class 5 (Pharmaceuticals).

View Xeris Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of August 18, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since August 18, 2026
Filed: April 19, 2024
Registered: August 18, 2026
Expires: Not recorded
Application no.: 98509233
Registration no.: 8403711
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 1 class

Ownership

Who owns GVOKE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Xeris Pharmaceuticals, Inc.

Chicago, United States

52 trademarks in the portfolioView company

Representative

Tracy-Gene G. Durkin

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Goods and services

What the mark covers

The products and services GVOKE is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

August 18, 2026Notice of registration confirmation emailed
August 18, 2026Registered-principal register
July 25, 2026Notice of acceptance of statement of use e-mailed
July 25, 2026Allowed principal register - sou accepted
July 20, 2026Statement of use processing complete
July 20, 2026Case assigned to intent to use paralegal
May 11, 2026Use amendment filed
May 11, 2026Teas statement of use received
November 18, 2025Notice of approval of extension request e-mailed
November 17, 2025Sou extension 1 granted

10 earlier steps on the official record.

FAQ

About GVOKE

Who owns the trademark "GVOKE"?

The USPTO trademark "GVOKE" (application 98509233) is owned by Xeris Pharmaceuticals, Inc.

What is the status of "GVOKE"?

Its status at the USPTO is: registered.

When was "GVOKE" registered?

It was registered on August 18, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GVOKE and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2cd0-fc94-74ee-9601-83b765616392
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2cd0-fc94-74ee-9601-83b765616392",
  "object": "trademark",
  "mark_text": "GVOKE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98509233",
  "filing_date": "2024-04-19",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Xeris Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbbf-baf3-7289-8af4-8beafc2d67cb"
    }
  ]
}